Literature DB >> 16618128

Asparagine deamidation: pH-dependent mechanism from density functional theory.

Baron Peters1, Bernhardt L Trout.   

Abstract

Asparagine deamidation is a decisive event in chemotherapy-induced apoptosis and a major obstacle in the formulation of monoclonal antibodies. Despite the importance of deamidation, little is known about the elementary reactions involved. B3LYP/6-31+G(d,p)/COSMO-RS calculations were used to obtain stable structures and transition states for a network of reactions. Calculated rate constants were incorporated into a kinetic model of the pH dependence and compared to a pseudo-steady-state model. At low pH, the calculations show that deamidation occurs by direct acid-catalyzed hydrolysis to aspartate. At neutral to basic pH, deamidation proceeds by the initial formation of a tetrahedral intermediate. The intermediate can be converted to succinimide by two pathways and three rate-determining steps that shift in relative importance with pH. The calculated pH-dependent rate constant qualitatively agrees with the experimental pH dependence. The rate-determining transition state structures may help to understand chemotherapy-induced apoptosis and improve protein formulations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618128     DOI: 10.1021/bi052438n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

Review 1.  Silk-based stabilization of biomacromolecules.

Authors:  Adrian B Li; Jonathan A Kluge; Nicholas A Guziewicz; Fiorenzo G Omenetto; David L Kaplan
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

2.  Use of 18O labels to monitor deamidation during protein and peptide sample processing.

Authors:  Xiaojuan Li; Jason J Cournoyer; Cheng Lin; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2008-03-05       Impact factor: 3.109

3.  Multivariate analysis of the sequence dependence of asparagine deamidation rates in peptides.

Authors:  Andrew A Kosky; Vasumathi Dharmavaram; Gayathri Ratnaswamy; Mark Cornell Manning
Journal:  Pharm Res       Date:  2009-09-09       Impact factor: 4.200

4.  Identification of aspartic and isoaspartic acid residues in amyloid beta peptides, including Abeta1-42, using electron-ion reactions.

Authors:  Nadezda P Sargaeva; Cheng Lin; Peter B O'Connor
Journal:  Anal Chem       Date:  2009-12-01       Impact factor: 6.986

Review 5.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

6.  Purification and identification of high molecular weight products formed during storage of neutral formulation of human insulin.

Authors:  Christian Fogt Hjorth; František Hubálek; Jonatan Andersson; Christian Poulsen; Daniel Otzen; Helle Naver
Journal:  Pharm Res       Date:  2015-01-14       Impact factor: 4.200

7.  Widespread Occurrence of Non-Enzymatic Deamidations of Asparagine Residues in Yersinia pestis Proteins Resulting from Alkaline pH Membrane Extraction Conditions.

Authors:  Moo-Jin Suh; Hamid Alami; David J Clark; Prashanth P Parmar; Jeffrey M Robinson; Shih-Ting Huang; Robert D Fleischmann; Scott N Peterson; Rembert Pieper
Journal:  Open Proteomics J       Date:  2008-01-01

8.  Evidence of the involvement of asparagine deamidation in the formation of cyclodextrin glycosyltransferase isoforms in Paenibacillus sp. RB01.

Authors:  Wanchai Yenpetch; Kanoktip Packdibamrung; Wolfgang Zimmermann; Piamsook Pongsawasdi
Journal:  Mol Biotechnol       Date:  2011-03       Impact factor: 2.695

9.  Thermodynamics and mechanism of protonated asparagine decomposition.

Authors:  Amy L Heaton; Peter B Armentrout
Journal:  J Am Soc Mass Spectrom       Date:  2009-01-09       Impact factor: 3.109

10.  Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products.

Authors:  Andrea Hawe; Robert Poole; Stefan Romeijn; Piotr Kasper; Rob van der Heijden; Wim Jiskoot
Journal:  Pharm Res       Date:  2009-04-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.